EU immigration

EU immigration

This subtopic contains the following guidance on EU level rules relating to immigration:

Practice Note: EU immigration policy—Key immigration Directives provides a high level overview of the EU immigration policy, with a look at the key Directives enacted since the EU was given powers to legislate on this matter in the late 90s. This overview examines the scope of the legislation, the conditions laid down for admission and residence for

To view the latest version of this document and thousands of others like it, sign-in with LexisNexis or register for a free trial.

TAKE A FREE TRIAL

Latest EU Law News

ICJ publishes advisory opinion on States’ climate change obligations

The International Court of Justice (ICJ) has published its advisory opinion on the obligations of States in respect of climate change. The ICJ unanimously held that climate change treaties, including the United Nations Framework Convention on Climate Change, the Kyoto Protocol, and the Paris Agreement, impose binding obligations on States parties to protect the climate system and the broader environment from anthropogenic greenhouse gas emissions. It further concluded that under international human rights law, States must respect and ensure the effective enjoyment of human rights by taking necessary measures to safeguard the climate and environment. The ICJ emphasised that any breach of these obligations by a State constitutes an internationally wrongful act that entails State responsibility. The responsible State remains under a continuing duty to fulfil the breached obligation. Legal consequences of such wrongful acts may include: (a) cessation of the wrongful actions or omissions, if ongoing; (b) provision of assurances and guarantees of non-repetition of wrongful actions or omissions, if required by the circumstances; and (c) full reparation to affected States through restitution, compensation or satisfaction, provided that the general conditions of the law of State responsibility are met.

WTO arbitrators issue award in IP dispute between EU and China

The World Trade Organization (WTO) has circulated the arbitration award in case DS611, China — Enforcement of Intellectual Property Rights, concluding appeal proceedings initiated by the EU under Article 25 of the Dispute Settlement Understanding (DSU). The dispute concerns China’s use of anti-suit injunctions (ASIs) in litigation involving standard-essential patents (SEPs), and an alleged unwritten ASI policy. The arbitration was conducted under the Multi-Party Interim Appeal Arbitration Arrangement (MPIA), following the suspension of panel proceedings in April 2025. The arbitrators reviewed the panel’s findings and considered whether China’s measures were consistent with obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), including Articles 1.1, 28.1, 28.2, 41.1, 44.1, 63.1 and 63.3.

EIOPA consults on rules for resolution colleges and reporting requirements under IRRD

The European Insurance and Occupational Pensions Authority (EIOPA) has launched two consultations on draft technical standards under the Insurance Recovery and Resolution Directive (Directive (EU) 2024/2979) (IRRD), which is expected to become operational in 2027. The first consultation concerns draft regulatory technical standards (RTS) on the establishment and functioning of resolution colleges, which will coordinate resolution planning and execution for insurance groups. The second covers draft implementing technical standards (ITS) specifying procedures and standardised templates for insurers to submit information to resolution authorities for the preparation of resolution plans. Responses to the consultations are sought by 31 October 2025.

EFPIA responds to Commission's new Multiannual Financial Framework proposal

The European Federation of Pharmaceutical Industries and Associations (EFPIA) issued a preliminary response on 18 July 2025 to the Commission's Multiannual Financial Framework package proposed on 16 July. While EFPIA welcomed the alignment with competitiveness compass objectives, it expressed concerns about insufficient prioritisation of health research funding and the proposed corporate lump-sum contribution mechanism.